The Future Of Plug-And-Play Large-Scale Viral Vector Manufacturing

Source: AGC Biologics

Adeno-associated viruses (AAV) are among the most common vectors used for ex-vivo and in-vivo gene therapies. Yet, despite hundreds of biotechnology and engineering studies, standard procedures for large-scale manufacturing of these vectors remain inconsistent.

Explore AAV-based gene therapy production, managing adherent and suspension processes, and new cost-effective and streamlined approaches for creating large-scale AAV production that can meet any product specification. This plug-and-play concept is built around using transient transfection with PEIpro, and an efficient and scalable off-the-shelf AAV vector production process that will get you to the manufacturing and clinical supply stage as quickly as possible, while reducing complex PD efforts.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online